City of Hope develops adaptive plug-and-play CAR T technology to attack tumors

The Medical News · 3d ago

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer.

Read original article on The Medical News →

City of Hope develops adaptive plug-and-play CAR T technology to attack tumors

Related news